TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Completed Radiation Treatment Plans Reviewed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Progression-Free Survival at 1 year and 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (AEs) arising during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life of patients during treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neck Disability index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Level of mobilization
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Effective Regurgitant Orifice Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of complete peritoneal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Periapical Index Score (PAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CMV reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: COPD and Asthma fatigue scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Dyspnea 12 scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Disagreement in TE results between operators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smallest detectable change (SDC95)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and Negative Affect Schedule Expanded (PANAS-X)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Prosthetic joint infections (PJI)
Endpoint domain: Adverse events/effects
Primary endpoint: Trans cutaneous CO2 (TCCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean overall weight loss response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of unsuspected metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change rate from baseline in Spot-UACR (Albumin/Creatinine Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Genetic status or polymorphism result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coefficient of determination (r2) of sodium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with Established Atherosclerotic Cardiovascular Disease (eASCVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in PSS-10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioral healthcare utilization cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Modified Overt Aggression Scale (MOAS) from baseline to 3 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful liberation of RRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Test of Infant Motor Performance Score (TIMP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to initiation of Early Intervention therapy services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Parent quality of life questionnaire assessed using the Peds QL Family Impact Module
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients with erector spinae muscle stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' intensive care experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sinonasal Outcome Test 22 (SNOT-22)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lund-Kennedy endoscopic grading system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic arterial stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of amyloid aggregate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Isometric Scapular Pinch Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Efficacy of topical treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Truelove and Witt's classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in health related quality of life (HRQoL) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fusobacterium sp presence in endometrial biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement rate of erosion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: AHI difference between Somfit and PSG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AHI difference between Somfit and WatchPAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Infants with Major Congenital Malformation
Endpoint domain: Mortality/survival
Primary endpoint: Performance of thermography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast cancer-related quality of life - total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of cycles aborted due to toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of episodes of allergic reactions in CTCAE grade 3 and 4
Endpoint domain: Adverse events/effects
Primary endpoint: Number of hematological toxicities in grade 3 and 4 CTCAE
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with dentin hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DELTA binding potential relative to non displaceable uptake (BPND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: GI Tolerance Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: musculoskeletal pain in the neck and shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: musculoskeletal pain in the lower back
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in the Scores of Parental Perinatal Distress Scale (PPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in the Scores of Multidimensional Scale for Perceived Social Support (MSPSS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in Blood Concentration Level for escitalopram, sertraline, and alprazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in mean Systolic Blood Pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in mean LDL-c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Return of Spontaneous Circulation (ROSC) at hospital
Endpoint domain: Mortality/survival
Primary endpoint: Change in hemoglobin, hematocrit, and reticulocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum observed plasma concentration of filgotinib (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero till the last observed quantifiable concentration of filgotinib (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration time curve from time zero to infinity of filgotinib (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of enteral microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of oral microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of oral BHB supplementation
Endpoint domain: Adverse events/effects
Primary endpoint: central venous catheter exchanges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of cases with PDA admitted
Endpoint domain: Mortality/survival
Primary endpoint: Mean number of scheduled sessions attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from Baseline in Area Under the Curve (AUC) of CGM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psoriasis Area Severity Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Assessment of Interoceptive Awareness (MAIA-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emergency front of neck access training effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial velocity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Vessels With Less Than or Equal to (<=) Grade 3 Hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Device-related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Brain activity - BOLD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EGFR expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lactate serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle Thickness Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression, Anxiety, and Stress Levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum Depression Levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: IBS-Visual Analogue Scale (IBS-VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Irritable Bowel Syndrome Symptom Severity Score (IBS/SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Irritable Bowel Syndrome Quality of Life Scale (IBS-QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of Participants Who Receive All Intervention Content (Fidelity)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of Participants with Complete Data (Assessment Completion)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction with the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Experienced pain measured on a Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of frequentation to the emergency department
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Functional Impairment - Neck Disability Index Score (NDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Participant Success Rate (M6-C Artificial Cervical Disc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with local lymph node metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Number of patients with toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of mucous plugging associated with airway stent
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of granuloma associated with airway stent
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of respiratory infection associated with airway stent
Endpoint domain: Adverse events/effects
Primary endpoint: Radiographic progression-free survival (rPFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Confirmed Allergy Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Baropodometric examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of new atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to achieving definite diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 Case identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Six minutes Walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEDsQL Parent proxy report format
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in provider guideline adherence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cholangitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Wound Healing Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Wound Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: peri-operative morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Canadian Occupational Performance Measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of performed TROD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of sessions performed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area under plasma concentration-time curve from time zero to the last measurable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Grade ≥3 systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Viral rebound defined as confirmed HIV-1 RNA >200 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Serum total estradiol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area under the curve (AUC(0 ∞))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time to reach maximum concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Half Life (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Score with VASI formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of hemorrhage, edema or other damages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between thermal imaging camera and axillary contact thermometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood and anxiety assessments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of all attributable toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Need for respiratory support persisting more than 1 hour after birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Admission to the Neonatal Intensive Care Unit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Burst abdomen
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in epileptic discharges on EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area under the concentration-time curve over the dosing interval (AUCtau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum serum concentration during the dosing interval (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of sub-maximal total exercise duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: orbito-naso-frontal bandeau conformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: angle criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: symmetry criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: receipt of tobacco cessation counseling
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: receipt of tobacco cessation medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of serum PSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: antibiotic prescribing rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Full mouth bleeding on probing scores (BOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anthropometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in black carbon levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thoresen scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of Anxiety and Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dyadic Coping
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in emotion regulation difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent of time ≥70% erect during overnight sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the QRISK3 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative risk of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Structured Assessment of Gastrointestinal Symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: European Quality of Life Five Dimension (EQ-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in parent sensitive and responsive care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in parental understanding of child social & emotional development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevention of child welfare out of home placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intestinal Fructose tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Renal Fructose tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepatic fructose tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of Vittel criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of True-Positives (sensitivity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of True-Negatives (specificity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in resident agitation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: absence of lower limb overgrowth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 3-year recurrence-free interval (3y-RFI)
Endpoint domain: Mortality/survival
Primary endpoint: Global health status decline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in subjective sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Brief Balance Evaluation Systems Test total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aging anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decline in applying to CCM fellowships
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Perception of pain during vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in BCVA score at week 80
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment burden as assessed by the treatment frequency up to Week 80
Endpoint domain: Resource use
Endpoint subdomain: Other resource use